OAB-023: Efficacy and safety of ciltacabtagene autoleucel, a BCMA-directed CAR-T cell therapy, in patients with progressive multiple myeloma after 1–3 prior lines of therapy: Initial results from CARTITUDE-2
Titel:
OAB-023: Efficacy and safety of ciltacabtagene autoleucel, a BCMA-directed CAR-T cell therapy, in patients with progressive multiple myeloma after 1–3 prior lines of therapy: Initial results from CARTITUDE-2
Auteur:
Cohen, Adam Agha, Mounzer Madduri, Deepu Cohen, Yael Delforge, Michel Hillengass, Jens Goldschmidt, Hartmut Weisel, Katja Raab, Marc-Steffen Scheid, Christoph Schecter, Jordan M. Braganca, Kevin C. De Varsos, Helen Wang, Liwei Vogel, Martin Carrasco-Alfonso, Marlene Akram, Muhammad Wu, Xiaoling Nesheiwat, Tonia Einsele, Hermann